Clinical Trials Browser

Terminated × Metformin × 1 year × Clear all

NCT02874430 2026-04-22

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Phase 2 Terminated

29 enrolled 11 charts

Breast Neoplasms

NCT02946996 2026-03-05

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase 2 Terminated

41 enrolled 8 charts

Prostatic Neoplasms

NCT03109847 2025-12-11

Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers

Phase 2 Terminated

13 enrolled 8 charts

Thyroid Diseases

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Phase 4 Terminated

3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT05536037 2025-05-15

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Phase 1 Terminated

Erythroplasia, Leukoplakia, Mouth Neoplasms

NCT01430351 2025-05-07

Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy

Phase 1 Terminated

Glioblastoma, Gliosarcoma